HDAC9 and inflammatory bowel disease: a novel tissueregenerative property of the pan-HDACinhibitors givinostat and vorinostat in intestinal inflammation, whichmay have beneficial implications by repurposing HDAC inhibitors fortherapeutic strategies for inflammatory bowel disease